LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells.
about
Deletional tolerance mediated by extrathymic Aire-expressing cellsTrans-species polymorphism in humans and the great apes is generally maintained by balancing selection that modulates the host immune responseMolecular diagnosis in autoimmune skin blistering conditionsTwo forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomainImmunopathology and molecular diagnosis of autoimmune bullous diseasesLaser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.Linear IgA bullous dermatosis.Clinical spectrum, pathogenesis and treatment of linear IgA bullous dermatosis.A potential peptide pathway from viruses to oral lichen planus.The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.Mechanisms of blister induction by autoantibodies.Direct and indirect immunofluorescence.The diagnosis and treatment of autoimmune blistering skin diseases.Pemphigoid diseases: pathogenesis, diagnosis, and treatment.Diagnosing epidermolysis bullosa type and subtype in infancy using immunofluorescence microscopy: the Stanford experience.Urban legend series: mucous membrane pemphigoid.A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence.DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases.IgE auto-reactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants.Non-paraneoplastic autoimmune subepidermal bullous disease associated with fatal bronchiolitis obliterans.Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans.Two type XVII collagen (BP180) mRNA transcripts in human keratinocytes: a long and a short form.Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasionImmunodissection of the connective tissue matrix in human skin.Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide.Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases.Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285.Substrate hydrolysis by matrix metalloproteinase-9.Long-Term Balancing Selection in LAD1 Maintains a Missense Trans-Species Polymorphism in Humans, Chimpanzees, and Bonobos.Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults.Humoral Epitope Spreading in Autoimmune Bullous Diseases.Diagnosis of Autoimmune Blistering Diseases
P2860
Q24652952-BB105B89-BFDB-4C57-A603-16F8C612C2FDQ26785914-8E0131F0-C07A-4F15-8445-104BE07273D8Q27025483-791AAFBB-E747-456B-9D53-B48BB1165CA5Q28283395-F5BADB41-F2F1-4EE6-A972-0F50C66802EBQ28303627-0847F29F-BEB3-405D-AC50-1D10DBA6CA60Q33226334-EAD0647E-F8B3-4E12-A8E5-00D780F5227DQ33785796-D386DB6D-3DE9-424B-8FFB-4AA0BCEBFBDFQ34480493-DB3799C9-2F95-4EDA-BCAF-6180A1E297EFQ35578860-5ED4D542-459C-418B-99E3-EA59323E732EQ35745439-58A78EA0-35EF-477F-BE9E-2E2CC81C6709Q36307954-7472BBB2-C8B8-42D5-9AED-C65DC288DFA7Q37800033-49D04277-6ACF-4983-9DCE-6B0EC05C2C23Q37895468-5F7B3914-5AD5-45DF-8CD3-CA65ED6D4C7BQ37933427-F1F34963-6112-4C2B-9581-213FE54D00E2Q38086601-A46C812A-434D-4545-9C34-31224BF06BDDQ38169809-38DEA638-A898-48FF-8D38-094347284592Q38376851-19DB2DB5-3FC0-408D-BCAD-28ED77273DBCQ38743845-4C9181AB-0F91-46CC-AD61-C2EEA971C708Q39534908-099148DA-DF7E-46C1-A28E-6D275980ECEBQ40068365-57193AC8-9F88-4ACB-8E92-0A014BCDBF6FQ40425512-53B2795A-AD86-46BE-AD62-16D974706483Q40868375-CC071DC3-B182-41B0-A6C4-987398089FCDQ40900428-8CAFB12C-607E-473B-88D1-4CFAFF7E8E28Q41348871-E9CF8A5C-EF64-432A-9E5C-0447D8592969Q41594132-E6852C55-4871-41E1-B1C1-BD2ED1B9D7CCQ42453753-3F032E90-5FA7-4844-A88D-BA2D4622E8DFQ42514770-F91F36B5-D106-4504-821F-28738F1A397BQ43817773-74C10ACD-8BA3-4E07-8E93-D230226B494CQ45736978-AD571C47-ED26-4E0A-9B3D-C5E61FBC6BB6Q46784241-471866EB-BB80-4933-8CF4-9B8485C22293Q48136064-BC87BD4C-CCFF-41B6-B39B-B6086FB59B61Q55262188-4C5BEA39-6505-4318-B0E7-C7EE28561700Q59132166-DBE2DF65-3224-4367-BB78-C1EAA077BDFB
P2860
LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells.
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@ast
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@en
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@nl
type
label
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@ast
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@en
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@nl
prefLabel
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@ast
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@en
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@nl
P2093
P1476
LAD-1, the linear IgA bullous ...... ynthesized by epidermal cells.
@en
P2093
Burgeson RE
Marinkovich MP
P2888
P304
P356
10.1111/1523-1747.EP12345782
P407
P577
1996-04-01T00:00:00Z
P5875
P6179
1002060373